Results 101 to 110 of about 2,535,651 (215)
Annals of HepatologyIntroduction and Objectives: The mechanisms of hepatic fat loss in late-stage metabolic dysfunction-associated fatty liver disease (MASLD) are enigmatic and the prognostic significance of low hepatic fat content (LHF) in chronic liver disease (CLD) is ...
Atsushi Nakamura +3 more
doaj +1 more source
Immune and Inflammatory Pathways in Non-Alcoholic Steatohepatitis (NASH). An update [PDF]
, 2019 Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public health problem. It is considered to be the hepatic manifestation of the metabolic syndrome.
Breaban, Iulia +10 more
core +1 more source
Variation in _PNPLA3_ is associated with outcomes in alcoholic liver disease [PDF]
, 2009 Two recent genome-wide association studies have described associations of SNP variants in _PNPLA3_ with nonalcoholic fatty liver and plasma liver enzyme levels in population based cohorts.
Chao Tian +4 more
core +2 more sources
Metabolic dysfunction-associated fatty liver disease: an update. [PDF]
Aust PrescrO'Halloran R +3 more
europepmc +1 more source
Advancing global equity in liver disease research funding: the case of metabolic dysfunction-associated and alcohol-associated liver disease. [PDF]
BMJ Open GastroenterolHuynh DJ +4 more
europepmc +1 more source
Echocardiographic Markers and Outcomes in End-Stage Liver Disease. [PDF]
J Clin MedRadu T, Iacob SM, Gheorghe L.
europepmc +1 more source
Pathophysiology of cystic fibrosis-related liver disease. [PDF]
Curr Opin GastroenterolPalmiotti A, Bertolini A, Fiorotto R.
europepmc +1 more source
Dengue Viral Infection and Associated Liver Disease. [PDF]
J Clin Transl HepatolDa Silva Santiago M, Wu GY.
europepmc +1 more source